Skip to content

APOTHEEK MONNISSEN

Active
Private limited companyfounded 2007active for 19 yearsDiestsesteenweg 283, 3010 Leuven, BelgiumKBO/BCE: BE 0893.128.488

From the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK MONNISSEN has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €119,689 and a net result of €90,384. Equity remains stable across the filed financial years (±1.9% per year). Its solvency ranks better than 31% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK MONNISSENActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 25-10-2007 Normal situation
Legal form
Private limited company
Registered office
Diestsesteenweg 283, 3010 Leuven
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.166.118.876 3010 Leuven, since 25-10-2007
Financial year end
31 December
Peppol
Reachable since 16-09-2025
Company details

Who decides

Board
  • Monnissen Management Besloten VennootschapDirector
Shareholders
Board & ownership

How it is doing

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€151,763
▼ 19.8%
Turnover
≈ €710,000
estimated
Profit
€90,384
▼ 29.6%
Equity
€119,689
▲ 9.5%
Total assets
€593,021
▼ 1.5%
2025 accounts 29 days early
Filed on 02-07-2026at the National Bank
Financials
Why 94raises riskSector: Retail trade (NACE 47)lowers riskSize: total assets €593,021Founded in 2007Figures for financial year 2025 (filed 02-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 56% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 45+2
equity 20.2% of total assets
Liquidity 46-7
short-term debt 67.2% · cash 25.4%
Profitability 88-7
return on assets 15.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.3%▲ +0.1 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025highest value 07-2025: 0.1%▼ -0.2 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.2%▲ +0.1 percentage points vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.85, compared with 0.88 in 2024, below 1; short-term debt: 67.2% and cash: 25.4% of total assets), and 79.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 36% on solvency, 45% on liquidity, 83% on profitability and 60% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €593,021
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 2007
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Figures for financial year 2025 (filed 02-07-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €119,689
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 days early
2024
37 days early
2023
27 days early
2022
34 days early
2021
17 days early
2020
36 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 30 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 2 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €90,384 8 years View

Documents

Annual accounts at the NBB

All 18 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about APOTHEEK MONNISSEN

What is the company number of APOTHEEK MONNISSEN?
0893.128.488. In Belgium the VAT number is the company number with BE in front: BE 0893.128.488.
Where is APOTHEEK MONNISSEN based?
The registered office is at Diestsesteenweg 283, 3010 Leuven.Company details
What does APOTHEEK MONNISSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK MONNISSEN?
Private limited company (BV).
When was APOTHEEK MONNISSEN founded?
On 25-10-2007.
Is APOTHEEK MONNISSEN still active?
Yes, APOTHEEK MONNISSEN is an active enterprise in the KBO register.
How many employees does APOTHEEK MONNISSEN have?
On average 0.2 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK MONNISSEN?
≈ €710,000 in financial year 2025. Estimated from the gross margin of €151,763: probably between €480,000 and €1.4m, based on 51 comparable companies, NACE 477.
Is APOTHEEK MONNISSEN profitable?
In financial year 2025, APOTHEEK MONNISSEN made a profit of €90,384.
Where can I find the annual accounts of APOTHEEK MONNISSEN?
APOTHEEK MONNISSEN filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK MONNISSEN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK MONNISSEN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure